Latest Medtech News
Top Stories
MedTech Europe report boosts optimism in ‘thriving’ EU medtech sectorMedTech Europe highlighted that there were 15,700 medtech patent applications in 2024, doubling the rate of those in pharma and biotech.
A new report by MedTech Europe indicates that Europe’s medical technology sector is continuing to innovate and grow in economic strength.
The trade body’s report revealed that Europe’s overall medical technology market was worth around €170bn ($198.6bn) in 2024, with the sector employing over 930,000 staff.
According to MedTech Europe, digital health is rapidly scaling in Europe as a result of the convergence between breakthrough technologies, patient empowerment, and systemic efficiencies.
Medical technology applications with the European Patent Office (EPO) came in at 15,700 in 2024, corresponding to 7.9% of all EPOs.
Measuring Medtech's M&A Appetite in 2025Medtech has already seen a strong showing of M&A activity this month, starting with Stryker announcing its intention to buy Inari Medical in a deal valued at $4.9 billion. Next came Boston Scientific pulling the trigger on Bolt Medical, a company it had invested in since 2019. We've even seen some acquisition activity on the supplier side of medtech, including Geon Performance Solutions acquiring Foster, and Phillips Medisize buying Vectura Group.
Is it too soon to get our hopes up for more to come on the medtech M&A front in 2025? We've combed through presentations from the J.P. Morgan Healthcare Conference that wrapped up last week, along with recent earnings reports, to find out which medtech companies are hungry for M&A this year and which companies are likely to be a bit more picky with their capital allocations. [...]
Abbott CEO: There's opportunities in med-tech, there's opportunities in diagnostics, and we're in a great position, and it allows us to be selective. [...]
J&J CEO: Larger opportunities have to be seen more like outliers. [...]
Medtronic CEO: We're on the hunt for tuck-in M&A. [...]
Boston Scientific CFO: The world is our oyster relative to M&A. [...]
GE HealthCare: Strong balance sheet allows for organic investment and opportunistic M&A. [...]
Latest News
- MedTech Europe report boosts optimism in ‘thriving’ EU medtech sector
- Terumo signs agreement to buy OrganOx for $1.5bn
- Alcon strikes $1.5bn deal to acquire rival STAAR Surgical
- Measuring Medtech's M&A Appetite in 2025
- Becton Dickinson looks to divest life sciences unit at $30 billion valuation, source says
- Teleflex announce acquisition of Biotronik’s Vascular Intervention business
- 3 Ways Robotic Surgery Is Changing Health Care In 2025
- Boston Scientific buys Israeli medical device co SoniVie
- Becton Dickinson looks to divest life sciences unit at $30 billion valuation
- Stryker to buy Inari Medical for nearly $5B
- Stryker buys out Nico Corporation to expand stroke care arm
- Edwards completes sale of Critical Care business to BD
- Edwards Lifesciences to spend $1.2B on two more M&A deals
- Bain M&A Midyear Report 2024: Dealmakers Mine Multiple Sources of Value
- Owens & Minor to acquire Rotech Healthcare for nearly $1.4B
- Hologic to buy Endomagnetics for $310M
- Medline enters deal to acquire Ecolab’s global surgical solutions business
- Ansell Acquires Kimberly-Clark's Protective Equipment Business For $640M
- Johnson & Johnson to Buy Shockwave Medical for $13.1 Billion
- Carl Zeiss completes $1B ophthalmic company buy
Let’s discuss about how we can work together on your next medtech project and
how I can add value to your business
Please contact us for a first discussion on your current projects, pipeline and portfolio.